194 related articles for article (PubMed ID: 29560769)
1. Expression of p53, Bcl-2 and Bax in endometrial carcinoma, endometrial hyperplasia and normal endometrium: a histopathological study.
Mirakhor Samani S; Ezazi Bojnordi T; Zarghampour M; Merat S; Fouladi DF
J Obstet Gynaecol; 2018 Oct; 38(7):999-1004. PubMed ID: 29560769
[TBL] [Abstract][Full Text] [Related]
2. Bax, Bcl-2, and p53 expression in endometrial cancer.
Sakuragi N; Salah-eldin AE; Watari H; Itoh T; Inoue S; Moriuchi T; Fujimoto S
Gynecol Oncol; 2002 Sep; 86(3):288-96. PubMed ID: 12217750
[TBL] [Abstract][Full Text] [Related]
3. Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic, and malignant endometrium.
Ioffe OB; Papadimitriou JC; Drachenberg CB
Hum Pathol; 1998 Oct; 29(10):1150-9. PubMed ID: 9781657
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis-related proteins and steroid hormone receptors in normal, hyperplastic, and neoplastic endometrium.
Bozdoğan O; Atasoy P; Erekul S; Bozdoğan N; Bayram M
Int J Gynecol Pathol; 2002 Oct; 21(4):375-82. PubMed ID: 12352186
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma.
Vaskivuo TE; Stenbäck F; Tapanainen JS
Cancer; 2002 Oct; 95(7):1463-71. PubMed ID: 12237915
[TBL] [Abstract][Full Text] [Related]
7. Cellular apoptosis susceptibility gene expression in endometrial carcinoma: correlation with Bcl-2, Bax, and caspase-3 expression and outcome.
Peiró G; Diebold J; Baretton GB; Kimmig R; Löhrs U
Int J Gynecol Pathol; 2001 Oct; 20(4):359-67. PubMed ID: 11603220
[TBL] [Abstract][Full Text] [Related]
8. Computerized image analysis of p53 and proliferating cell nuclear antigen expression in benign, hyperplastic, and malignant endometrium.
Elhafey AS; Papadimitriou JC; El-Hakim MS; El-Said AI; Ghannam BB; Silverberg SG
Arch Pathol Lab Med; 2001 Jul; 125(7):872-9. PubMed ID: 11419970
[TBL] [Abstract][Full Text] [Related]
9. Changes in expression of some apoptotic markers in different types of human endometrium.
Driák D; Dvorská M; Svandová I; Sehnal B; Benková K; Spůrková Z; Halaška M
Folia Biol (Praha); 2011; 57(3):104-11. PubMed ID: 21888833
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis and the expression of Bax and Bcl-2 in hyperplasia and adenocarcinoma of the uterine endometrium.
Kokawa K; Shikone T; Otani T; Nishiyama R; Ishii Y; Yagi S; Yamoto M
Hum Reprod; 2001 Oct; 16(10):2211-8. PubMed ID: 11574518
[TBL] [Abstract][Full Text] [Related]
11. Utility of Ki-67, p53, Bcl-2, and Cox-2 biomarkers for low-grade endometrial cancer and disordered proliferative/benign hyperplastic endometrium by imprint cytology.
Apostolou G; Apostolou N; Biteli M; Kavantzas N; Patsouris E; Athanassiadou P
Diagn Cytopathol; 2014 Feb; 42(2):134-42. PubMed ID: 23729350
[TBL] [Abstract][Full Text] [Related]
12. Significantly decreased P27 expression in endometrial carcinoma compared to complex hyperplasia with atypia (correlation with p53 expression).
Ozkara SK; Corakci A
Pathol Oncol Res; 2004; 10(2):89-97. PubMed ID: 15188025
[TBL] [Abstract][Full Text] [Related]
13. Proliferative and apoptotic changes in the healthy canine endometrium and in cystic endometrial hyperplasia.
Reusche N; Beineke A; Urhausen C; Beyerbach M; Schmicke M; Kramer S; Günzel-Apel AR
Theriogenology; 2018 Jul; 114():14-24. PubMed ID: 29574305
[TBL] [Abstract][Full Text] [Related]
14. bcl-2 protein expression in endometrial carcinoma: the lack of correlation with p53.
Miturski R; Semczuk A; Tomaszewski J; Jakowicki J
Cancer Lett; 1998 Nov; 133(1):63-9. PubMed ID: 9929161
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry.
Morsi HM; Leers MP; Radespiel-Tröger M; Björklund V; Kabarity HE; Nap M; Jäger W
Gynecol Oncol; 2000 Apr; 77(1):11-7. PubMed ID: 10739685
[TBL] [Abstract][Full Text] [Related]
16. [The Expression of Pokemon in Endometrial Carcinoma Tissue and the Correlation with Mutant p53].
Yi TJ; Wang P
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 May; 47(3):321-5. PubMed ID: 27468473
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of the von Hippel-Lindau gene in human endometrial hyperplasia and endometrial carcinoma.
Xu JY; Zhu WJ; Cao XZ; Li XF; Wu J
Int J Gynecol Cancer; 2011 Apr; 21(3):430-4. PubMed ID: 21436690
[TBL] [Abstract][Full Text] [Related]
18. [Assessment of the PCNA and P53 proteins expression in the proliferative, hyperplastic and neoplastic human endometrium].
Zawiślak W; Semczuk A; Miturski R
Ginekol Pol; 2001 Dec; 72(12A):1549-54. PubMed ID: 11883313
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of steroid receptors, proliferation markers, apoptosis related molecules, and gelatinases in non-neoplastic and neoplastic endometrium.
Amalinei C; Cianga C; Balan R; Cianga P; Giusca S; Caruntu ID
Ann Anat; 2011 Feb; 193(1):43-55. PubMed ID: 21145716
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of PTEN in normal, hyperplastic and malignant endometrium and its correlation with hormone receptors, bcl-2, bax, and apoptotic index.
Kapucuoglu N; Aktepe F; Kaya H; Bircan S; Karahan N; Ciriş M
Pathol Res Pract; 2007; 203(3):153-62. PubMed ID: 17317031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
